FDA-Drug2026-03-11Class IMISBRANDING
SILINTAN 25 pills recalled for undeclared meloxicam ingredient
What this means
SILINTAN 25 pills, sold in 25-count bottles, contain an undeclared ingredient called meloxicam, a prescription pain reliever. The FDA found this ingredient was not listed on the label and the product was not approved by the FDA. The recall affects all lots currently in use.
- Stop taking SILINTAN 25 pills immediately
- Do not use any remaining pills from the bottle
- Contact your doctor or pharmacist if you have taken this product and need guidance
- Consult a healthcare provider before starting any replacement product
The agency's original wording
Hazard
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Intended for
Adults
Illnesses reported
None reported
Sold states
USA nationwide
Affected count
N/A
Manufactured in
7214 Berne St, N/A, Rosemead, CA, United States
Products
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0388-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering people with food allergies — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.